Welcome to our dedicated page for Pennant Group SEC filings (Ticker: PNTG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Pennant Group, Inc. (NASDAQ: PNTG) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as a public Delaware corporation. Pennant is the holding company for independent operating subsidiaries that provide home health, hospice, home care and senior living services across multiple states, and its filings offer detailed insight into this structure and its financial results.
Users can review current reports on Form 8-K in which Pennant describes material events such as acquisitions, credit facility amendments and quarterly earnings releases. For example, the company has filed 8-Ks covering its Amended and Restated Credit Agreement and a First Amendment that added an incremental term loan facility, as well as 8-Ks documenting the completion of acquisitions from UnitedHealth Group and Amedisys related to home health, hospice and palliative care operations.
Amended 8-K filings (8-K/A) on this page include additional information required by SEC rules, such as audited and unaudited abbreviated financial statements of acquired businesses and unaudited pro forma condensed combined financial statements. These documents help readers understand how significant acquisitions may affect Pennant’s financial position and results.
In addition to event-driven filings, investors can access Pennant’s periodic reports on Forms 10-K and 10-Q, which contain full financial statements, segment disclosures for home health and hospice services and senior living services, and discussions of risk factors and non-GAAP metrics. The platform also surfaces filings related to earnings announcements, where Pennant furnishes press releases under Item 2.02 and provides Regulation FD disclosures under Item 7.01.
Stock Titan enhances these documents with AI-powered summaries that explain key sections of lengthy filings, highlight important items such as acquisition terms, credit facility covenants and segment performance, and help readers quickly identify the most relevant information in Pennant’s regulatory history.
Pennant Group (PNTG) reported an insider equity grant. A director acquired 2,400 shares of common stock on 10/15/2025 (transaction code A, award at $0), with these shares vesting in three annual installments beginning October 15, 2026. Following the transaction, the director beneficially owns 51,735 shares, held directly.
Pennant Group, Inc. (PNTG) disclosed a director’s option exercise. On 10/09/2025, the director exercised a stock option to acquire 10,000 shares of common stock at $11.35 per share (Transaction Code: M), increasing direct beneficial ownership to 94,899 shares following the transaction. The option was first exercisable on 07/17/2024, has an expiration date of 07/17/2033, and a 33% portion vested in 2025.
The Pennant Group, Inc. filed an amended current report to update a previously furnished press release. This 8-K/A modifies Item 7.01 of the original October 2, 2025 filing by replacing Exhibit 99.1 with an amended press release.
The updated Exhibit 99.1 is described as an amended press release dated October 2, 2025 announcing the closing of a transaction. No other items from the original report are changed, and the company clarifies that the information in Item 7.01 and Exhibit 99.1 is furnished, not filed, for securities law purposes.
The Pennant Group, Inc. amended its previously announced purchase agreement with UnitedHealth Group and Amedisys to expand the scope of a planned acquisition of home health, hospice, and palliative care businesses. The amendment adds additional entities and assets to be acquired by Pennant’s subsidiaries, including Cornerstone Healthcare, Tensaw River Healthcare, Threemile River Healthcare, and Bashaw River Healthcare. As a result, the total purchase price has been increased from $102,484,000 to $146,531,160, reflecting the larger portfolio of operations to be acquired.
The Pennant Group, Inc. completed a cash acquisition of certain home health, hospice, and palliative care operations from subsidiaries of UnitedHealth Group and Amedisys on October 1, 2025. Through its subsidiaries Cornerstone Healthcare, Inc. and Tensaw River Healthcare LLC, Pennant acquired specified equity interests and assets related to these service providers for $146,531,160 in cash, subject to post‑closing adjustments. The company later issued a press release announcing the closing of this transaction.
Pennant Group, Inc. Schedule 13G/A reports that FMR LLC and Abigail P. Johnson together beneficially hold 1,071,334.13 shares of Pennant Group common stock, representing 3.1% of the class. The filing shows FMR LLC has sole voting power over 1,068,803 shares and sole dispositive power over 1,071,334.13 shares; Abigail P. Johnson reports sole dispositive power for the same aggregate amount and no voting power. The filing is dated as an event on 08/29/2025 and signed on 09/05/2025. The Schedule references Exhibit 99 for a 13d-1(k)(1) agreement and incorporates powers of attorney by reference.
8 Knots affiliates disclosed a 7.70% stake in The Pennant Group, Inc. (PNTG). The filing shows 8 Knots Management, LLC and Scott Green each report beneficial ownership of 2,652,806 shares, representing 7.70% of the 34,468,981 shares outstanding used for the calculation. Holdings are held across funds and separately managed accounts: 8 Knots Fund (1,403,748 shares, 4.07%), 8 Knots Fund II (117,516 shares, 0.34%), and aggregate SMA holdings of 887,959 shares. 8 Knots Management is the adviser to the funds and SMAs and disclaims beneficial ownership of certain sub-advised and SMA positions where agreements are terminable. The filing includes a joint filing agreement signed August 7, 2025.